Turning Point 2023
A selection of articles from the 2023 issue of Turning Point.
How Dana-Farber is spearheading new strategies to correct historical trends and disparities in cancer care and prevention
Antibody-drug conjugates — a kind of molecular "smart bomb" — are emerging as an important form of targeted treatment across a variety of cancers
How Dana-Farber researchers are helping cancer patients get the tools they need to lead fulfilling daily lives
How Dana-Farber's environment of collaboration sparks new clinical trials and results in a far-reaching impact
The curiosity and tenacity of individual researchers can spark unforeseen advances and breakthroughs.
Turning Point is published for supporters of the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute.
Comments, suggestions, and requests to be added to or deleted from the mailing list may be sent to:
Request a Publication
Receive by mail the current issue of a Dana-Farber publication by completing this request form.
The Media Team cannot respond to patient inquiries. For more information on contacting Dana-Farber, please see Contact Us.